Electrolyte Disorders and Renal Transport Mechanisms

The kidneys maintain systemic electrolyte balance through coordinated processes of filtration, reabsorption and secretion along distinct nephron segments. Electrolytes such as sodium, potassium and chloride are transported by specialised membrane proteins—including the sodium–chloride cotransporter, the sodium–potassium–chloride cotransporter and epithelial sodium channels—whose activity is modulated by hormonal and intracellular signalling cascades. Central among these are the with-no-lysine kinases (WNKs) and their downstream effectors SPAK/OSR1, which adjust transporter phosphorylation in response to changes in plasma and intracellular ion concentrations. Disruptions of these mechanisms give rise to dyskalaemias, hyponatraemia or hypernatraemia, each carrying significant cardiovascular and neurological consequences. Genetic tubulopathies such as Gitelman and Bartter syndromes illustrate how mutations in transporter genes or regulatory components (for example CLCNKB) result in chronic electrolyte imbalances, hypotension or salt wasting. Clinically, understanding the interplay between dietary intake, pharmacological agents (such as thiazide diuretics) and intrinsic renal signalling is vital for the management of hypertension, heart failure and chronic kidney disease. Advances in molecular physiology and high‐resolution genomic techniques continue to refine our grasp of nephron segment–specific transport and open avenues for targeted therapies that correct or compensate for defective electrolyte handling.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Electrolyte Disorders and Renal Transport Mechanisms publication trend

The graph below shows the total number of articles in electrolyte disorders and renal transport mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Sodium–chloride cotransporter (NCC): A thiazide‐sensitive membrane protein in the distal convoluted tubule that reabsorbs Na+ and Cl– ions.

WNK kinases: A family of serine/threonine kinases that regulate ion transporters via phosphorylation of SPAK/OSR1 in response to chloride and volume changes.

Protein phosphatase 1A (PP1A): A serine/threonine phosphatase that dephosphorylates key transport proteins, modulating their activity in electrolyte handling.

Dyskalaemia: A clinical term for abnormal serum potassium levels, encompassing both hypokalaemia and hyperkalaemia.

Distal convoluted tubule (DCT): A nephron segment immediately downstream of the macula densa, critical for fine‐tuning sodium, potassium and divalent cation balance.

References

1. Dietary potassium stimulates Ppp1Ca-Ppp1r1a dephosphorylation of kidney NaCl co-transporter and reduces blood pressure. Journal of Clinical Investigation (2023).
2. Long-read sequencing identifies a common transposition haplotype predisposing for CLCNKB deletions. Genome Medicine (2023).
3. Potassium homeostasis – Physiology and pharmacology in a clinical context. Pharmacology & Therapeutics (2023).
4. WNK Kinase Signaling in Ion Homeostasis and Human Disease. Cell Metabolism (2017).
5. WNK1 Regulates Phosphorylation of Cation-Chloride-coupled Cotransporters via the STE20-related Kinases, SPAK and OSR1*. Journal of Biological Chemistry (2005).
6. Distal Convoluted Tubule. Clinical Journal of the American Society of Nephrology (2014).